483RNov 4, 2022

483R Document: Boehringer Ingelheim Fremont, Inc.

Jeffrey P. Raimondi, FDA Investigator Christopher R. Czajka, FDA Investigator

FDANews 483R Boehringer Ingelheim Fremont, Inc. Nov 4 2022 top

Jeffrey P. Raimondi FDA Investigator Christopher R. Czajka FDA Investigator

FDA inspected Boehringer Ingelheim Fremont, Inc.'s Fremont site on Nov 04, 2022. See how they responded.